FDA Clearance Tracker · P130008-S124
INSPIRE II UPPER AIRWAY STIMULATOR
Last checked: Nov 20, 2026Latest source record: Feb 6, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 6, 2026
Approved
Time to decision
284 days
Received Apr 28, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P130008-S124
- Device name
- INSPIRE II UPPER AIRWAY STIMULATOR
- Applicant
- Inspire Medical Systems
- Applicant location
- Maple Grove, MN
- Received
- Apr 28, 2025
- Decided
- Feb 6, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P130008
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
labeling changes to include 3.0T magnetic resonance imaging (MRI) scanning conditions.
Source documents
Other decisions for Inspire Medical Systems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Inspire Upper Airway Stimulation SystemPMA supplement
P130008-S090 · Decided Jun 8, 2023 · 234 days after receipt · Panel Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.